首页> 外文OA文献 >The relationship between hormone receptor status, tumor size and clinical stage and the efficacy of neoadjuvant chemotherapy for locally advanced breast cancer, predictors of survival, and the establishment of Cox-Based risk prediction model and nomogram

【2h】

The relationship between hormone receptor status, tumor size and clinical stage and the efficacy of neoadjuvant chemotherapy for locally advanced breast cancer, predictors of survival, and the establishment of Cox-Based risk prediction model and nomogram

机译：激素受体状态，肿瘤大小和临床阶段的关系以及Neoadjuvant化疗对局部晚期乳腺癌，存活预测因子的疗效，以及基于Cox的风险预测模型的建立和探测图

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Gan Fengjiao; Xu Mengxi; Li Xiaomei; Wang Lian; Zhang Mingyue; Xu Lin; Wu Qiaoyuan; Jiang Ni; Hu Kang; Li Yi; Sun Suhong; Luo Qing;
展开▼
作者单位

展开▼
年度 2020
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Clinical and Pathological Response to Neoadjuvant Chemotherapy Based on Primary Tumor Reduction is Correlated to Survival in Hormone Receptor-Positive but not Hormone Receptor-Negative Locally Advanced Breast Cancer [J] . Chen Sheng, Liu Yin, Ouyang Qian-Wen, Annals of surgical oncology . 2015,第1期

机译：基于原发性肿瘤减少的新辅助化疗的临床和病理反应与激素受体阳性而非激素受体阴性的局部晚期乳腺癌的存活率相关
2. Clinical and Pathological Response to Neoadjuvant Chemotherapy Based on Primary Tumor Reduction is Correlated to Survival in Hormone Receptor-Positive but not Hormone Receptor-Negative Locally Advanced Breast Cancer [J] . Chen Sheng, Liu Yin, Ouyang Qian-Wen, Annals of surgical oncology . 2015,第1期

机译：基于原发性肿瘤减少的Neoadjuvant化疗的临床和病理反应与激素受体阳性的生存存在相关，但不是激素受体 - 负局部晚期乳腺癌
3. Tumour molecular subtyping according to hormone receptors and HER2 status defines different pathological complete response to neoadjuvant chemotherapy in patients with locally advanced breast cancer [J] . Alfonso Sánchez-Mu?oz, Ana María García-Tapiador, Esther Martínez-Ortega, Clinical and Translational Oncology . 2008,第10期

机译：根据激素受体和HER2状态的肿瘤分子分型定义了局部晚期乳腺癌患者对新辅助化疗的不同病理完全反应
4. Early identification of non-responding locally advanced breast tumors receiving neoadjuvant chemotherapy [C] . Martijn van de Giessen, Boudewijn E. Schaafsma, Ayoub Charehbili, Photonic therapeutics and diagnostics XI . 2015

机译：早期鉴定接受新辅助化疗的无反应的局部晚期乳腺肿瘤
5. Development and Validation of a Nomogram to Predict Pathological Complete Response to Neoadjuvant Chemotherapy for Breast Cancer. [D] . Yang, Victoria Qi. 2015

机译：诺法图的开发和验证，以预测对乳腺癌新辅助化学疗法的病理完全反应。
6. Nomogram basing pre-treatment parameters predicting early response for locally advanced rectal cancer with neoadjuvant chemotherapy alone: a subgroup efficacy analysis of FOWARC study [O] . Jianwei Zhang, Yue Cai, Huabin Hu, 2016

机译：基于治疗前参数的诺法图可预测仅使用新辅助化疗对局部晚期直肠癌的早期反应：FOWARC研究的亚组疗效分析
7. Nomogram basing pre-treatment parameters predicting early response for locally advanced rectal cancer with neoadjuvant chemotherapy alone: a subgroup efficacy analysis of FOWARC study [O] . Jianwei Zhang, Yue Cai, Huabin Hu, 2015

机译：NOMACHOM基于单独的Neoadjuvant化疗预测局部晚期直肠癌早期反应的预处理参数：FOWARC学习的亚组疗效分析

The relationship between hormone receptor status, tumor size and clinical stage and the efficacy of neoadjuvant chemotherapy for locally advanced breast cancer, predictors of survival, and the establishment of Cox-Based risk prediction model and nomogram

著录项

引文网络

相似文献

相关主题

期刊订阅